Fulcrum Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Fulcrum Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results

Fulcrum Therapeutics Inc. (FULC) Tops Q4 EPS by 8c

March 4, 2021 7:14 AM EST

Fulcrum Therapeutics Inc. (NASDAQ: FULC) reported Q4 EPS of ($0.64), $0.08 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $4.23 million versus the consensus estimate of $1.31 million.

For earnings history and earnings-related data on Fulcrum Therapeutics Inc. (FULC) click here.

... More